Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Protagonist Therapeutics Inc (PTGX)

16.89 -1.08 (-6.01%)

02-22 16:00

Open:

18

Pre. Close:

17.97

High:

18

Low:

16.8

Volume:

75,194

Market Cap:

346M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

18.023 - 18.11

18.11 - 18.197

Low:

16.75 - 16.857

16.857 - 16.961

Close:

16.804 - 16.972

16.972 - 17.137

Technical analysis  (as of: 2018-02-22 5:02:21 PM)

Overall:

      

Stoxline posted a SELL today, downgraded from higher rating. This stock seems to be ready for a new bearish move. So you may continue to hold short positions or sell your long positions. You are relatively safe to short or sell now, downward move is expected.

Target:

Six months: 24.42     One year: 27.74

Support:

Support1: 16.32    Support2: 13.58

Resistance:

Resistance1: 20.91    Resistance2: 23.75

Pivot:

18.27

Moving Averages:

MA(5): 17.35     MA(20): 18.99

MA(100): 18.33     MA(250): 14.79

MACD:

MACD(12,26): -0.73     Signal(12,26,9): -0.55

%K %D:

%K(14,3): 11.48     %D(3): 12.16

RSI:

RSI(14): 40.55

52-Week:

High: 23.75  Low: 8  Change(%): 18.1

Average Vol(K):

3-Month: 10869  10-Days 7379

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PTGX has closed above bottom band by 31.9%. Bollinger Bands are 63% wider than normal. The large width of the bands suggest high volatility as compared to PTGX's normal range. The bands have been in this wide range for 14 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Jan 2018 12:56:15 GMT
Protagonist Therapeutics Granted Two New US Patents for Peptide Drug ...

Tue, 30 May 2017 10:52:30 GMT
Protagonist Therapeutics Enters into Worldwide Agreement with Janssen to Co ...

Wed, 18 Oct 2017 11:21:58 GMT
Protagonist Therapeutics Inc.

Thu, 14 Dec 2017 11:33:12 GMT
Protagonist Therapeutics Appoints Sarah Noonberg, MD, Ph.D. to the Board of ...

Wed, 11 Oct 2017 19:52:30 GMT
Protagonist Therapeutics Announces Proposed Public Offering of Common Stock

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

20.48

Shares Float (M)

20.28

% Held by Insiders

% Held by Institutions

54.80

Shares Short (K)

663

Shares Short Prior Month (K)

405

Stock Financials

EPS

-2.690

EPS Est. Current Year

EPS Est. Next Year

-2.250

EPS Est. Next Quarter

-0.690

Forward EPS

1.#IO

Book Value (p.s.)

6.220

PEG Ratio

Profit Margin

Operating Margin

-521.36

Return on Assets (ttm)

-41.5

Return on Equity (ttm)

-56.6

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.218

Qtrly Earnings Growth

Operating Cash Flow (M)

8.34

Levered Free Cash Flow (M)

22.13

atoplab.com

Valuation

P/E

-6.32

P/E Growth Ratio

-0.05

P/BV

2.73

P/S

669538496.00

P/CF

41.75

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.